Matthew Ciorba, MD
IBD Immunology and Emerging Therapies: Where Are We and Where We Are Going
Joel Pekow, MD, MPH
Sara Horst, MD, MPH
Parambir S. Dulai, MD
Kara DeFelice, MD
Current Therapies and Those in the Pipeline Q & A
What is New in Anti -TNFs and Anti-Integrins?
Small Molecules (JAKi/S1P agonists)
IL-12/23 and IL-23 Receptor Antagonists
Sushila R. Dalal, MD
Virtual IBD Clinic: Updates in Diagnostic, Therapeutic, and Prognostic Strategies
Virtual IBD Clinic: Updates in Diagnostic, Therapeutic, and Prognostic Strategi…
Jenny S. Sauk, MD
Virtual IBD Clinic: Surgical and Pharmacological Therapeutics
2022 Crohn's & Colitis Congress
Neilanjan Nandi, MD
Jean-Frederic Colombel, MD
Emerging Therapies in UC
Loading...
Stay current with the best on medical education
We’re glad to see you’re enjoying Crohn's Colitis Professional…but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.
